221 related articles for article (PubMed ID: 32640103)
1. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
Muilwijk T; Akand M; Soria F; Giordano A; Milenkovic U; Moris L; Gevaert T; Van Poppel H; Albersen M; Gontero P; Joniau S
BJU Int; 2020 Dec; 126(6):704-714. PubMed ID: 32640103
[TBL] [Abstract][Full Text] [Related]
2. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
Kim HS; Kwak C; Kim HH; Ku JH
Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
[TBL] [Abstract][Full Text] [Related]
3. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
Welty CJ; Sanford TH; Wright JL; Carroll PR; Cooperberg MR; Meng MV; Porten SP
Cancer; 2017 Dec; 123(23):4574-4582. PubMed ID: 28881475
[TBL] [Abstract][Full Text] [Related]
4. The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance.
Colomer Gallardo A; Candela L; Buisan Rueda O; Freixa Sala R; Elias Cañavera J; Moschini M; Macek P; Bennamoun M; Mombet A; Cathelineau X; Areal Calama JJ; Sánchez-Salas R
Clin Genitourin Cancer; 2022 Jun; 20(3):199-209. PubMed ID: 35042666
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
6. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
7. Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study.
De Nunzio C; Franco A; Simone G; Tuderti G; Anceschi U; Brassetti A; Daneshmand S; Miranda G; Desai MM; Gill I; Abol-Enein H; Molinaro E; Nacchia A; Lombardo R; Leonardo C; Tubaro A
Eur J Surg Oncol; 2021 Oct; 47(10):2646-2650. PubMed ID: 33966945
[TBL] [Abstract][Full Text] [Related]
8. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
9. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
[TBL] [Abstract][Full Text] [Related]
10. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience.
Khanna A; Miest T; Sharma V; Campbell R; Hensley P; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Murthy PB; Haber GP; Navai N; Kamat AM; Dinney C; Lee B; Boorjian SA
J Urol; 2022 Mar; 207(3):551-558. PubMed ID: 34694143
[TBL] [Abstract][Full Text] [Related]
11. Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?
Choi SY; You D; Hong B; Hong JH; Ahn H; Kim CS
Surg Oncol; 2019 Sep; 30():109-116. PubMed ID: 31500772
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
Front Oncol; 2022; 12():895413. PubMed ID: 35928878
[TBL] [Abstract][Full Text] [Related]
13. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
[TBL] [Abstract][Full Text] [Related]
14. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
[TBL] [Abstract][Full Text] [Related]
15. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
16. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
[TBL] [Abstract][Full Text] [Related]
17. Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
Huddart RA; Birtle A; Maynard L; Beresford M; Blazeby J; Donovan J; Kelly JD; Kirkbank T; McLaren DB; Mead G; Moynihan C; Persad R; Scrase C; Lewis R; Hall E
BJU Int; 2017 Nov; 120(5):639-650. PubMed ID: 28453896
[TBL] [Abstract][Full Text] [Related]
18. The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study.
Wahafu W; Liu S; Xu W; Wang M; He Q; Song L; Wang M; Yang F; Hua L; Niu Y; Xing N
BMC Urol; 2019 Nov; 19(1):117. PubMed ID: 31733646
[TBL] [Abstract][Full Text] [Related]
19. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
[TBL] [Abstract][Full Text] [Related]
20. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]